Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer’s Disease

Published:2009-06-26 Issue:2 Volume:183 Page:1375-1383
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Fonseca Maria I.,Ager Rahasson R.,Chu Shu-Hui,Yazan Ozkan,Sanderson Sam D.,LaFerla Frank M.,Taylor Stephen M.,Woodruff Trent M.,Tenner Andrea J.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference72 articles.

1. Terry, R. D., E. Masliah, L. A. Hansen. 1999. The neuropathology of Alzheimer disease and the structural basis of its cognitive alteration. R. D. Terry, and R. Katzman, and K. L. Bick, and S. S. Sisodia, eds. Alzheimer Disease 2nd Ed.187-206. Lippincott Williams & Wilkins, New York.

2. Pathological tau: a loss of normal function or a gain in toxicity?

3. The role of cerebral amyloid accumulation in common forms of Alzheimer disease

4. Characterization of the Drosophila melanogaster genome at the nuclear lamina

5. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term high fat diet impairs memory, exacerbates the neuroimmune response, and evokes synaptic degradation via a complement-dependent mechanism in a mouse model of Alzheimer’s disease;Brain, Behavior, and Immunity;2024-10

2. Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States;Proteins: Structure, Function, and Bioinformatics;2024-09

3. Therapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease;Cells;2024-08-26

4. C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer’s disease mouse model;Nature Communications;2024-08-15

5. Complement C5a receptor 1 blockade reverses cognitive deficits following cranial radiation therapy for brain cancer;2024-07-04